THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis

Background Behçet’s Disease (BD) is a systemic inflammatory disorder characterized by vasculitis that is usually accompanied by oral and genital ulcers, skin lesions, uveitis and arthritis. Increased neutrophil activity and hyperresponsiveness to streptococci have been considered to play a role in B...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.232-233
Hauptverfasser: Akdeniz, T., Demirel, G.Y., Karakas, M., Bicakcigil, M., Direskeneli, H., Deyneli, O., Yavuz, S.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 233
container_issue Suppl 3
container_start_page 232
container_title Annals of the rheumatic diseases
container_volume 71
creator Akdeniz, T.
Demirel, G.Y.
Karakas, M.
Bicakcigil, M.
Direskeneli, H.
Deyneli, O.
Yavuz, S.
description Background Behçet’s Disease (BD) is a systemic inflammatory disorder characterized by vasculitis that is usually accompanied by oral and genital ulcers, skin lesions, uveitis and arthritis. Increased neutrophil activity and hyperresponsiveness to streptococci have been considered to play a role in Behçet’s disease (BD) pathogenesis. Objectives We previously showed that testosterone (T) may also play a role in BD pathogenesis via increasing neutrophil activity and decreasing neutrophil apoptosis. Here we aimed further to define the effects of testosterone in detail. Methods Twelve BD patients who were in remission at least 6 months were included in this study. Peripheral blood from patient and 20 controls (10 ankylosing spondylitis/10 healthy donors) groups were drawn into heparinized Vacutainer tubes (BD BioSciences, USA). None of the patients were on any immunosuppressive treatment other than colchicum dispert 1.5gr/d. Neutrophils were incubated with testosterone, CpG DNA (5’-TCG ATC GGG GCG GGG CGA GC-3’, XX IDT) and lipoteichoic acid (LTA) and in combinations of Ts + LTA and Ts + CpG DNA. Activation degree of neutrophils after a 2 hour incubation were analyzed by Dihydrorhodamine 123 conversion to rhodamine as a result of mitochondria activation. Culture supernatants were collected for cytokine measurements. FC500 flow cytometer and CXP software were used for analysis. IL-1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, INF-gamma, TNF-alpha were assessed by using Th1/Th2 11plex RTU FlowCytomix Kit (BenderMed/e-Bioscience, Austria) on FC500 cytometry. Results Testosterone caused neutrophil activation in all groups, however, LTA and CpGDNA activated neutrophils in combination with T exclusively in BD (LTA vs LTA/T 66.2±23.7 vs82.3±22.5 p
doi_str_mv 10.1136/annrheumdis-2012-eular.2194
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1777977155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4008660761</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1655-439e5c38ad4c18ea9ab927f1844d8ba9dca6d9c7ee11022dcff530a388c118513</originalsourceid><addsrcrecordid>eNqVkMtO3DAUhq2qlTqFvoMl1gGfXHxpV9VQOqgUhDogdpbjHHcyJPFgJ1K7Y9OH4PV4knoYVLFlZR3r-89vf4QcADsEKPiRGYawwqlv2pjlDPIMp86EwxxU-YbMoOQyXXP2lswYY0VWKi7ekw8xrtPIJMgZ6ZeLK5bn6vH-7_FkOorOoR0j9Y6OGEcfRwx-QNoOtMaVxfHx_iHS1Icm4id62m-61pqx9UOkzgdqaPDdE_7M0I0ZV_4XDhjbuE_eOdNF_Ph87pGrk6_L-SI7u_h2Ov9yltXAqyorC4WVLaRpSgsSjTK1yoUDWZaNrI1qrOGNsgIRID2-sc5VBTOFlBZAVlDskYPd3k3wd1P6h177KQypUoMQQgkBVZWozzvKBh9jQKc3oe1N-KOB6a1f_cKv3vrVT3711m9KZ7t0mxz9_h814VZzUYhKn1_P9c8fy_L75Q1onni-4-t-_aqif3lYmHc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777977155</pqid></control><display><type>article</type><title>THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis</title><source>BMJ Journals - NESLi2</source><creator>Akdeniz, T. ; Demirel, G.Y. ; Karakas, M. ; Bicakcigil, M. ; Direskeneli, H. ; Deyneli, O. ; Yavuz, S.</creator><creatorcontrib>Akdeniz, T. ; Demirel, G.Y. ; Karakas, M. ; Bicakcigil, M. ; Direskeneli, H. ; Deyneli, O. ; Yavuz, S.</creatorcontrib><description><![CDATA[Background Behçet’s Disease (BD) is a systemic inflammatory disorder characterized by vasculitis that is usually accompanied by oral and genital ulcers, skin lesions, uveitis and arthritis. Increased neutrophil activity and hyperresponsiveness to streptococci have been considered to play a role in Behçet’s disease (BD) pathogenesis. Objectives We previously showed that testosterone (T) may also play a role in BD pathogenesis via increasing neutrophil activity and decreasing neutrophil apoptosis. Here we aimed further to define the effects of testosterone in detail. Methods Twelve BD patients who were in remission at least 6 months were included in this study. Peripheral blood from patient and 20 controls (10 ankylosing spondylitis/10 healthy donors) groups were drawn into heparinized Vacutainer tubes (BD BioSciences, USA). None of the patients were on any immunosuppressive treatment other than colchicum dispert 1.5gr/d. Neutrophils were incubated with testosterone, CpG DNA (5’-TCG ATC GGG GCG GGG CGA GC-3’, XX IDT) and lipoteichoic acid (LTA) and in combinations of Ts + LTA and Ts + CpG DNA. Activation degree of neutrophils after a 2 hour incubation were analyzed by Dihydrorhodamine 123 conversion to rhodamine as a result of mitochondria activation. Culture supernatants were collected for cytokine measurements. FC500 flow cytometer and CXP software were used for analysis. IL-1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, INF-gamma, TNF-alpha were assessed by using Th1/Th2 11plex RTU FlowCytomix Kit (BenderMed/e-Bioscience, Austria) on FC500 cytometry. Results Testosterone caused neutrophil activation in all groups, however, LTA and CpGDNA activated neutrophils in combination with T exclusively in BD (LTA vs LTA/T 66.2±23.7 vs82.3±22.5 p<0.05; CpGDNA vs CpGDNA/T 62.2±23.6 vs 84.7±13.4 p<0.02)When we further analyze the effect of T onto cytokines in different conditions, we observed that T induce IL-10 secretion (unstimulated vs stimulated 9.6±1.01 vs 15.9±4.3 p<0.003)in HC. Whereas, T led to elevated IL-12 levels (BD: 15.1±4.6 vs 21.4±5.4 p<0.002; AS:14.1±2.4 vs20.5±5.9 p<0.006) in both BD and AS and increased INFg only in AS. Interestingly, TNF-a levels were increased with LTA in both BD (18.5±7.0 vs 28.4±16.0 p<0.01) and AS (16.5±1.7 vs 31.6±25.3 p<0.03) compared to HC but significantly elevated IL-4 levels were observed in BD patients (103.2±42.5) compared to AS (19.5±2.8) and HC (17.6±3.4) when stimulation occurred with LTA+T (p<0.0001). Similarly, CpGDNA+T induced significant upregulation of TNF-a (18.5±7.0 vs 57.4±52.1 p<0.02) in BD patients but also led to increase in IL-4 levels in BD (93.1±37.2) compared to AS (18.3±3.5,p<0.0001) and HC (20.1±2.4,p<0.01). Conclusions Despite immunosuppressive behavior in healthy subjects, T causes TH1 type immune alterations in BD patients and AS patients. The higher amount of IL-4 stimulation seen with uniquely in BD patients might be related to IL-4 gene polymorphism which is suggested to be a susceptibility factor to BD. Disclosure of Interest None Declared]]></description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/annrheumdis-2012-eular.2194</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>Kidlington: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><ispartof>Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.232-233</ispartof><rights>2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><rights>Copyright: 2013 (c) 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttp://ard.bmj.com/content/71/Suppl_3/232.3.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttp://ard.bmj.com/content/71/Suppl_3/232.3.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,780,784,3194,23570,27923,27924,77371,77402</link.rule.ids></links><search><creatorcontrib>Akdeniz, T.</creatorcontrib><creatorcontrib>Demirel, G.Y.</creatorcontrib><creatorcontrib>Karakas, M.</creatorcontrib><creatorcontrib>Bicakcigil, M.</creatorcontrib><creatorcontrib>Direskeneli, H.</creatorcontrib><creatorcontrib>Deyneli, O.</creatorcontrib><creatorcontrib>Yavuz, S.</creatorcontrib><title>THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description><![CDATA[Background Behçet’s Disease (BD) is a systemic inflammatory disorder characterized by vasculitis that is usually accompanied by oral and genital ulcers, skin lesions, uveitis and arthritis. Increased neutrophil activity and hyperresponsiveness to streptococci have been considered to play a role in Behçet’s disease (BD) pathogenesis. Objectives We previously showed that testosterone (T) may also play a role in BD pathogenesis via increasing neutrophil activity and decreasing neutrophil apoptosis. Here we aimed further to define the effects of testosterone in detail. Methods Twelve BD patients who were in remission at least 6 months were included in this study. Peripheral blood from patient and 20 controls (10 ankylosing spondylitis/10 healthy donors) groups were drawn into heparinized Vacutainer tubes (BD BioSciences, USA). None of the patients were on any immunosuppressive treatment other than colchicum dispert 1.5gr/d. Neutrophils were incubated with testosterone, CpG DNA (5’-TCG ATC GGG GCG GGG CGA GC-3’, XX IDT) and lipoteichoic acid (LTA) and in combinations of Ts + LTA and Ts + CpG DNA. Activation degree of neutrophils after a 2 hour incubation were analyzed by Dihydrorhodamine 123 conversion to rhodamine as a result of mitochondria activation. Culture supernatants were collected for cytokine measurements. FC500 flow cytometer and CXP software were used for analysis. IL-1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, INF-gamma, TNF-alpha were assessed by using Th1/Th2 11plex RTU FlowCytomix Kit (BenderMed/e-Bioscience, Austria) on FC500 cytometry. Results Testosterone caused neutrophil activation in all groups, however, LTA and CpGDNA activated neutrophils in combination with T exclusively in BD (LTA vs LTA/T 66.2±23.7 vs82.3±22.5 p<0.05; CpGDNA vs CpGDNA/T 62.2±23.6 vs 84.7±13.4 p<0.02)When we further analyze the effect of T onto cytokines in different conditions, we observed that T induce IL-10 secretion (unstimulated vs stimulated 9.6±1.01 vs 15.9±4.3 p<0.003)in HC. Whereas, T led to elevated IL-12 levels (BD: 15.1±4.6 vs 21.4±5.4 p<0.002; AS:14.1±2.4 vs20.5±5.9 p<0.006) in both BD and AS and increased INFg only in AS. Interestingly, TNF-a levels were increased with LTA in both BD (18.5±7.0 vs 28.4±16.0 p<0.01) and AS (16.5±1.7 vs 31.6±25.3 p<0.03) compared to HC but significantly elevated IL-4 levels were observed in BD patients (103.2±42.5) compared to AS (19.5±2.8) and HC (17.6±3.4) when stimulation occurred with LTA+T (p<0.0001). Similarly, CpGDNA+T induced significant upregulation of TNF-a (18.5±7.0 vs 57.4±52.1 p<0.02) in BD patients but also led to increase in IL-4 levels in BD (93.1±37.2) compared to AS (18.3±3.5,p<0.0001) and HC (20.1±2.4,p<0.01). Conclusions Despite immunosuppressive behavior in healthy subjects, T causes TH1 type immune alterations in BD patients and AS patients. The higher amount of IL-4 stimulation seen with uniquely in BD patients might be related to IL-4 gene polymorphism which is suggested to be a susceptibility factor to BD. Disclosure of Interest None Declared]]></description><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqVkMtO3DAUhq2qlTqFvoMl1gGfXHxpV9VQOqgUhDogdpbjHHcyJPFgJ1K7Y9OH4PV4knoYVLFlZR3r-89vf4QcADsEKPiRGYawwqlv2pjlDPIMp86EwxxU-YbMoOQyXXP2lswYY0VWKi7ekw8xrtPIJMgZ6ZeLK5bn6vH-7_FkOorOoR0j9Y6OGEcfRwx-QNoOtMaVxfHx_iHS1Icm4id62m-61pqx9UOkzgdqaPDdE_7M0I0ZV_4XDhjbuE_eOdNF_Ph87pGrk6_L-SI7u_h2Ov9yltXAqyorC4WVLaRpSgsSjTK1yoUDWZaNrI1qrOGNsgIRID2-sc5VBTOFlBZAVlDskYPd3k3wd1P6h177KQypUoMQQgkBVZWozzvKBh9jQKc3oe1N-KOB6a1f_cKv3vrVT3711m9KZ7t0mxz9_h814VZzUYhKn1_P9c8fy_L75Q1onni-4-t-_aqif3lYmHc</recordid><startdate>20130601</startdate><enddate>20130601</enddate><creator>Akdeniz, T.</creator><creator>Demirel, G.Y.</creator><creator>Karakas, M.</creator><creator>Bicakcigil, M.</creator><creator>Direskeneli, H.</creator><creator>Deyneli, O.</creator><creator>Yavuz, S.</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>Elsevier Limited</general><scope>BSCLL</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20130601</creationdate><title>THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis</title><author>Akdeniz, T. ; Demirel, G.Y. ; Karakas, M. ; Bicakcigil, M. ; Direskeneli, H. ; Deyneli, O. ; Yavuz, S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1655-439e5c38ad4c18ea9ab927f1844d8ba9dca6d9c7ee11022dcff530a388c118513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Akdeniz, T.</creatorcontrib><creatorcontrib>Demirel, G.Y.</creatorcontrib><creatorcontrib>Karakas, M.</creatorcontrib><creatorcontrib>Bicakcigil, M.</creatorcontrib><creatorcontrib>Direskeneli, H.</creatorcontrib><creatorcontrib>Deyneli, O.</creatorcontrib><creatorcontrib>Yavuz, S.</creatorcontrib><collection>Istex</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Akdeniz, T.</au><au>Demirel, G.Y.</au><au>Karakas, M.</au><au>Bicakcigil, M.</au><au>Direskeneli, H.</au><au>Deyneli, O.</au><au>Yavuz, S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2013-06-01</date><risdate>2013</risdate><volume>71</volume><issue>Suppl 3</issue><spage>232</spage><epage>233</epage><pages>232-233</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract><![CDATA[Background Behçet’s Disease (BD) is a systemic inflammatory disorder characterized by vasculitis that is usually accompanied by oral and genital ulcers, skin lesions, uveitis and arthritis. Increased neutrophil activity and hyperresponsiveness to streptococci have been considered to play a role in Behçet’s disease (BD) pathogenesis. Objectives We previously showed that testosterone (T) may also play a role in BD pathogenesis via increasing neutrophil activity and decreasing neutrophil apoptosis. Here we aimed further to define the effects of testosterone in detail. Methods Twelve BD patients who were in remission at least 6 months were included in this study. Peripheral blood from patient and 20 controls (10 ankylosing spondylitis/10 healthy donors) groups were drawn into heparinized Vacutainer tubes (BD BioSciences, USA). None of the patients were on any immunosuppressive treatment other than colchicum dispert 1.5gr/d. Neutrophils were incubated with testosterone, CpG DNA (5’-TCG ATC GGG GCG GGG CGA GC-3’, XX IDT) and lipoteichoic acid (LTA) and in combinations of Ts + LTA and Ts + CpG DNA. Activation degree of neutrophils after a 2 hour incubation were analyzed by Dihydrorhodamine 123 conversion to rhodamine as a result of mitochondria activation. Culture supernatants were collected for cytokine measurements. FC500 flow cytometer and CXP software were used for analysis. IL-1, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, INF-gamma, TNF-alpha were assessed by using Th1/Th2 11plex RTU FlowCytomix Kit (BenderMed/e-Bioscience, Austria) on FC500 cytometry. Results Testosterone caused neutrophil activation in all groups, however, LTA and CpGDNA activated neutrophils in combination with T exclusively in BD (LTA vs LTA/T 66.2±23.7 vs82.3±22.5 p<0.05; CpGDNA vs CpGDNA/T 62.2±23.6 vs 84.7±13.4 p<0.02)When we further analyze the effect of T onto cytokines in different conditions, we observed that T induce IL-10 secretion (unstimulated vs stimulated 9.6±1.01 vs 15.9±4.3 p<0.003)in HC. Whereas, T led to elevated IL-12 levels (BD: 15.1±4.6 vs 21.4±5.4 p<0.002; AS:14.1±2.4 vs20.5±5.9 p<0.006) in both BD and AS and increased INFg only in AS. Interestingly, TNF-a levels were increased with LTA in both BD (18.5±7.0 vs 28.4±16.0 p<0.01) and AS (16.5±1.7 vs 31.6±25.3 p<0.03) compared to HC but significantly elevated IL-4 levels were observed in BD patients (103.2±42.5) compared to AS (19.5±2.8) and HC (17.6±3.4) when stimulation occurred with LTA+T (p<0.0001). Similarly, CpGDNA+T induced significant upregulation of TNF-a (18.5±7.0 vs 57.4±52.1 p<0.02) in BD patients but also led to increase in IL-4 levels in BD (93.1±37.2) compared to AS (18.3±3.5,p<0.0001) and HC (20.1±2.4,p<0.01). Conclusions Despite immunosuppressive behavior in healthy subjects, T causes TH1 type immune alterations in BD patients and AS patients. The higher amount of IL-4 stimulation seen with uniquely in BD patients might be related to IL-4 gene polymorphism which is suggested to be a susceptibility factor to BD. Disclosure of Interest None Declared]]></abstract><cop>Kidlington</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><doi>10.1136/annrheumdis-2012-eular.2194</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-4967
ispartof Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.232-233
issn 0003-4967
1468-2060
language eng
recordid cdi_proquest_journals_1777977155
source BMJ Journals - NESLi2
title THU0229 Dual effects of testosterone in behcet’s disease: Implications for a role in disease pathogenesis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A50%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=THU0229%E2%80%85Dual%20effects%20of%20testosterone%20in%20behcet%E2%80%99s%20disease:%20Implications%20for%20a%20role%20in%20disease%20pathogenesis&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Akdeniz,%20T.&rft.date=2013-06-01&rft.volume=71&rft.issue=Suppl%203&rft.spage=232&rft.epage=233&rft.pages=232-233&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/annrheumdis-2012-eular.2194&rft_dat=%3Cproquest_cross%3E4008660761%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1777977155&rft_id=info:pmid/&rfr_iscdi=true